Pacira BioSciences reported preliminary unaudited net product sales of $44.6 million for April 2021, with EXPAREL contributing $43.1 million and iovera° contributing $1.5 million. EXPAREL average daily sales were 449% of April 2020.
Net product sales for April 2021 reached $44.6 million, driven by EXPAREL and iovera°.
EXPAREL sales for April 2021 were $43.1 million, with daily sales 449% higher than April 2020.
iovera° sales for April 2021 amounted to $1.5 million.
The company is encouraged by the growing demand for EXPAREL and iovera° as opioid-sparing pain control solutions.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance